The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ARIAD Pharmaceuticals Inc

Nasdaq: ARIA
Last

(U.S.) $13.94

Today's change-0.20 -1.41%
Updated September 29 11:05 AM EDT. Delayed by at least 15 minutes.
 

ARIAD Pharmaceuticals Inc

Nasdaq: ARIA
Last

(U.S.) $13.94

Today's change-0.20 -1.41%
Updated September 29 11:05 AM EDT. Delayed by at least 15 minutes.

Reversal following new 52-week high

ARIAD Pharmaceuticals Inc is lower today, dropping (U.S.)$0.20 or 1.41% to (U.S.)$13.94 after setting a new 52-week high. Over the last five days, shares have gained 2.27% and are currently 2.24% off of the 52-week high. Shares have outperformed the S&P 500 by 125.09% during the last year.

Key company metrics

  • Open(U.S.) $14.03
  • Previous close(U.S.) $14.14
  • High(U.S.) $14.15
  • Low(U.S.) $13.85
  • Bid / Ask(U.S.) $13.94 / (U.S.) $13.95
  • YTD % change+123.04%
  • Volume1,647,463
  • Average volume (10-day)8,401,333
  • Average volume (1-month)5,616,546
  • Average volume (3-month)5,329,374
  • 52-week range(U.S.) $4.37 to (U.S.) $14.26
  • Beta1.84
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.33
Updated September 29 11:05 AM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue68363729
Total other revenue--------
Total revenue68363729
Gross profit67353629
Total cost of revenue1000
Total operating expense80838985
Selling / general / administrative34364437
Research & development43444548
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)23----
Other operating expenses, total--------
Operating income-12-48-53-56
Interest income (expense), net non-operating-5-5-5-5
Gain (loss) on sale of assets--------
Other--------
Income before tax112-54-58-61
Income after tax110-54-60-55
Income tax, total202-6
Net income110-54-60-55
Total adjustments to net income--------
Net income before extra. items110-54-60-55
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items110-54-60-55
Inc. avail. to common incl. extra. items110-54-60-55
Diluted net income110-54-60-55
Dilution adjustment--000
Diluted weighted average shares195190189189
Diluted EPS excluding extraordinary itemsvalue per share0.56-0.28-0.32-0.29
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.57-0.27-0.32-0.29